• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ki67、c-erbB-2 和 c-kit 抗原在良恶性嗜铬细胞瘤中的免疫组化表达。

Immunohistochemical expression of Ki67, c-erbB-2, and c-kit antigens in benign and malignant pheochromocytoma.

机构信息

Department of Pathology, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Pathol Res Pract. 2010 May 15;206(5):305-9. doi: 10.1016/j.prp.2010.01.007. Epub 2010 Mar 1.

DOI:10.1016/j.prp.2010.01.007
PMID:20189725
Abstract

In this study, we evaluated the immunohistochemical expression and the possible advantages of Ki67 antigen, c-erbB-2, and c-kit proto-oncogenes in the differentiation between benign and malignant pheochromocytomas. Paraffin-embedded tissue blocks from 44 benign (35 adrenal and 9 extra-adrenal) and 11 malignant (9 adrenal and 2 extra-adrenal) cases of pheochromocytoma were selected for immunohistochemical staining using antibodies against Ki67, c-erbB-2, and c-kit antigens. We investigated the relationship between the expression of these antigens and age, gender, tumor size, histologic patterns and necrosis, as well as tumor behavior. The risk of malignancy was higher when tumor size was increased. We found out that more uncommon tissue patterns, such as small cell and spindle cell patterns, are mostly indicators of malignancy. There was a statistically significant relationship between Ki67- and c-erbB-2-positive staining of the tumor cells and the malignant behavior of the pheochromocytomas (p-value=0.000), while cytoplasmic c-kit staining did not show any correlation with tumor malignancy (p-value=0.087). We concluded that tumor size and the histomorphologic patterns (spindle cell and small round cell) are significantly associated with tumor behavior. In addition, Ki67 positivity and c-erbB-2 expression can be used as immunohistochemical markers for predicting the malignant behavior of pheochromocytoma.

摘要

在这项研究中,我们评估了 Ki67 抗原、c-erbB-2 和 c-kit 原癌基因在良恶性嗜铬细胞瘤鉴别诊断中的免疫组织化学表达和可能的优势。选择 44 例良性(35 例肾上腺和 9 例肾上腺外)和 11 例恶性(9 例肾上腺和 2 例肾上腺外)嗜铬细胞瘤的石蜡包埋组织块,用针对 Ki67、c-erbB-2 和 c-kit 抗原的抗体进行免疫组织化学染色。我们研究了这些抗原的表达与年龄、性别、肿瘤大小、组织学模式和坏死以及肿瘤行为之间的关系。当肿瘤增大时,恶性风险更高。我们发现,更不常见的组织模式,如小细胞和梭形细胞模式,大多是恶性的指标。肿瘤细胞 Ki67 和 c-erbB-2 阳性染色与嗜铬细胞瘤的恶性行为之间存在统计学显著关系(p 值=0.000),而细胞质 c-kit 染色与肿瘤恶性程度无相关性(p 值=0.087)。我们得出结论,肿瘤大小和组织形态学模式(梭形细胞和小圆细胞)与肿瘤行为显著相关。此外,Ki67 阳性和 c-erbB-2 表达可用作预测嗜铬细胞瘤恶性行为的免疫组织化学标志物。

相似文献

1
Immunohistochemical expression of Ki67, c-erbB-2, and c-kit antigens in benign and malignant pheochromocytoma.Ki67、c-erbB-2 和 c-kit 抗原在良恶性嗜铬细胞瘤中的免疫组化表达。
Pathol Res Pract. 2010 May 15;206(5):305-9. doi: 10.1016/j.prp.2010.01.007. Epub 2010 Mar 1.
2
Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior.利用DNA流式细胞术和细胞增殖免疫组化标记物预测嗜铬细胞瘤转移:MIB-1染色与恶性肿瘤行为之间呈正相关。
Cancer. 1999 Oct 15;86(8):1583-9.
3
Immunohistochemical estimations of growth activity to predict biological behavior of pheochromocytomas.通过免疫组织化学评估生长活性以预测嗜铬细胞瘤的生物学行为。
Mod Pathol. 1999 Dec;12(12):1107-11.
4
[Pheochromocytoma--pathohistologic and immunohistochemical aspects].[嗜铬细胞瘤——病理组织学和免疫组织化学方面]
Srp Arh Celok Lek. 2002 Jul;130 Suppl 2:7-13.
5
KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.KI-67和hTERT的表达有助于区分恶性和良性嗜铬细胞瘤及副神经节瘤。
Mod Pathol. 2003 Mar;16(3):246-55. doi: 10.1097/01.MP.0000056982.07160.E3.
6
[The significance of Ki-67 antigen expression in the distinction between benign and malignant pheochromocytomas].[Ki-67抗原表达在鉴别良性与恶性嗜铬细胞瘤中的意义]
Zhonghua Wai Ke Za Zhi. 2007 Dec 15;45(24):1697-700.
7
The role of immunohistochemistry in histopathological diagnostics of clinically "silent" incidentally detected adrenal masses.免疫组织化学在临床“无症状”偶然发现的肾上腺肿块组织病理学诊断中的作用。
Exp Clin Endocrinol Diabetes. 2008 Apr;116(4):246-51. doi: 10.1055/s-2007-993164.
8
Prognostic value of p53, bcl-2, and c-erbB-2 protein expression in phaeochromocytomas.p53、bcl-2和c-erbB-2蛋白表达在嗜铬细胞瘤中的预后价值
J Pathol. 1999 May;188(1):51-5. doi: 10.1002/(SICI)1096-9896(199905)188:1<51::AID-PATH310>3.0.CO;2-R.
9
The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study.钙视网膜蛋白、抑制素、黑色素A、BCL-2和C-kit在鉴别肾上腺皮质和髓质肿瘤中的作用:一项免疫组织化学研究。
Mod Pathol. 2003 Jun;16(6):591-7. doi: 10.1097/01.MP.0000073134.60541.E8.
10
Prognostic value of immunohistochemical expression of topoisomerase alpha II, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu in adrenal and extra-adrenal pheochromocytomas.拓扑异构酶α II、MIB-1、p53、E-钙黏蛋白、视网膜母细胞瘤基因蛋白产物及HER-2/neu在肾上腺及肾上腺外嗜铬细胞瘤中的免疫组化表达的预后价值
Appl Immunohistochem Mol Morphol. 2000 Dec;8(4):267-74.

引用本文的文献

1
Comprehensive Investigation of Angiogenesis, PASS Score and Immunohistochemical Factors in Risk Assessment of Malignancy for Paraganglioma and Pheochromocytoma.副神经节瘤和嗜铬细胞瘤恶性风险评估中血管生成、PASS评分及免疫组化因素的综合研究
Diagnostics (Basel). 2024 Apr 19;14(8):849. doi: 10.3390/diagnostics14080849.
2
Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas.影像引导下精准医学在嗜铬细胞瘤和副神经节瘤诊断与治疗中的应用
Cancers (Basel). 2023 Sep 21;15(18):4666. doi: 10.3390/cancers15184666.
3
Metastatic pheochromocytoma and paraganglioma: a retrospective multicentre analysis on prognostic and predictive factors to chemotherapy.
转移性嗜铬细胞瘤和副神经节瘤:化疗预后及预测因素的回顾性多中心分析
Ecancermedicalscience. 2023 Mar 20;17:1523. doi: 10.3332/ecancer.2023.1523. eCollection 2023.
4
Diagnostic, Prognostic, and Predictive Role of Ki67 Proliferative Index in Neuroendocrine and Endocrine Neoplasms: Past, Present, and Future.Ki67 增殖指数在神经内分泌和内分泌肿瘤中的诊断、预后和预测作用:过去、现在和未来。
Endocr Pathol. 2023 Mar;34(1):79-97. doi: 10.1007/s12022-023-09755-3. Epub 2023 Feb 17.
5
Promoter Methylation of Four Tumor Suppressor Genes in Human Papillary Thyroid Carcinoma.人甲状腺乳头状癌中四个抑癌基因的启动子甲基化
Iran J Pathol. 2019 Fall;14(4):290-298. doi: 10.30699/ijp.2019.94401.1922. Epub 2019 Sep 22.
6
The Impact Of Gene (SDH) Mutations In Renal Cell Carcinoma (RCC): A Systematic Review.基因(SDH)突变在肾细胞癌(RCC)中的影响:一项系统综述。
Onco Targets Ther. 2019 Sep 26;12:7929-7940. doi: 10.2147/OTT.S207460. eCollection 2019.
7
The Emerging Role of Succinate Dehyrogenase Genes (SDHx) in Tumorigenesis.琥珀酸脱氢酶基因(SDHx)在肿瘤发生中的新作用。
Int J Hematol Oncol Stem Cell Res. 2019 Apr 1;13(2):72-82.
8
Oncometabolites: A new insight for oncology.代谢物:肿瘤学的新视角。
Mol Genet Genomic Med. 2019 Sep;7(9):e873. doi: 10.1002/mgg3.873. Epub 2019 Jul 18.
9
Adrenal Collision Tumor Composed of Pheochromocytoma and Diffuse Large B-Cell Lymphoma: A Case Report.由嗜铬细胞瘤和弥漫性大B细胞淋巴瘤组成的肾上腺碰撞瘤:一例报告
Int J Hematol Oncol Stem Cell Res. 2018 Oct 1;12(4):249-252.
10
Liquid Biopsy in Thyroid Cancer: New Insight.甲状腺癌中的液体活检:新见解
Int J Hematol Oncol Stem Cell Res. 2018 Jul 1;12(3):235-248.